The rheumatic disorder therapy area is multi-disciplinary in nature and encompasses conditions that affect joints, connective tissue, ligaments, tendons, cartilage, bone and muscle and which are characterized by chronic pain and a consequent reduction in function and motion. The majority of rheumatic disorders are treated using largely genericized pain management drugs, and there are no cures for any of the key indications, leaving a large unmet need for better disease-modifying drugs to be ... Read more

The Mena Biologics and Biosimilars Market is estimated to be valued at US$ 502.2 Mn in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
The Mena biologics and biosimilars market consists of biologic drug products primarily used for the treatment of chronic diseases like diabetes, ... Read more

Monoclonal antibodies (mAbs) are monoclonal antibody therapeutics that are designed to bind to very specific sites on abnormal cells and proteins. They work by interrupting specific cell-signaling pathways that promote the growth and spread of cancer cells. mAbs are developed to target particular tumor antigens that are expressed on certain cancer cell types and not others. This high specificity reduces the non-specific toxicities associated with traditional chemotherapies. Key application ... Read more